Ed Tucker M.D.

Ed Tucker MD MBA has a diverse and extensive work experience spanning various leadership roles in the healthcare industry. Ed currently serves as the Chief Medical Officer at Jasper Therapeutics, a position they have held since June 2023. Prior to this, from 2020 to 2023, they worked as a Golden Seeds Investor at Golden Seeds. Before that, from 2022 to 2023, they served as the Chief Medical Officer at Goldfinch Bio.

From 2019 to 2021, Ed Tucker worked as the Chief Medical Officer at Mirum Pharmaceuticals. Their previous experience includes roles at Acerta Pharma B.V. (A member of the AstraZeneca Group), Genentech, Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Bayer HealthCare, and ConvaTec.

At Acerta Pharma B.V., Ed Tucker held several leadership positions, including Chief Operating Officer, SVP Clinical Development and Medical Safety, SVP Medical Safety, Quality and Compliance, and VP, Head of Medical Safety. During their tenure at Acerta Pharma B.V., they played a key role in ensuring patient safety, driving regulatory compliance, and overseeing quality assurance.

With their background in the pharmaceutical industry, Ed Tucker also held positions at Genentech as the VP and Head of Safety Science, PDS, and at Johnson & Johnson Pharmaceutical Research & Development, L.L.C as the VP, Global Medical Safety.

Earlier in their career, Ed Tucker gained valuable experience in the National Health Service (NHS) as a Physician, specializing in internal medicine and cardiology. Ed completed their training in Leeds and attained membership to the Royal College of Physicians (Edinburgh).

Starting their career as a Lab Tech at ConvaTec, Ed Tucker began to develop their skills and knowledge in the healthcare industry.

Overall, Ed Tucker MD MBA has a strong background in healthcare leadership, with a focus on medical safety, compliance, and patient care.

Ed Tucker MD MBA has a diverse education history. Ed obtained a BSc in Pharmacology from the University of Leeds in 1994. From 1990 to 1996, they pursued a degree in Medicine from the same university. In 1999, they obtained an MRCP degree in Medicine from the Royal College of Physicians in Edinburgh, UK. Ed furthered their medical education by completing a DPM degree in Pharmaceutical Medicine at Cardiff University / Prifysgol Caerdydd in 2002. Finally, they pursued an MBA degree in Management from the University of Connecticut, which they obtained in 2008.